Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402
- Citation:
- J Clin Oncol vol 27 (27) 4487-4491
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 630
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA047577, CA33601, CA47577, U10 CA045564, CA41287, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA045389, CA45389, CA45808, U10 CA041287, CA45564, CA31946
- Corr. Author:
- Authors:
- Rogerio Lilenbaum Xiaofei Wang Lin Gu Jeffrey Kirshner Keith Lerro Everett Vokes
- Networks:
- Study
- CALGB-30402
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Thor5, Original Reports, Thoracic Oncology